Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma: a Single Center Prospective Study

NCT06564363 is registered in ClinicalTrials.gov with Wuhan Ammunition Life-tech Co., Ltd as lead sponsor.

NCT NCT06564363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06564363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma: a Single Center Prospective Study
Lead sponsor
Wuhan Ammunition Life-tech Co., Ltd
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
December 31, 2025
Enrollment
148 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma